2 unknown, 1 active not recruiting, 1 terminated. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 2, Active not recruiting 1, Terminated 1 |
| Phase 1 | 2 | Terminated 1, Unknown 1 |
Follow SC: new trials by email Literature Review of SC trials Research Report on SC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimizing Outcomes for Young Autistic Children Social Communication, Disruptive Behavior, Social Communication + Reduce Frequency - Autism, Autism Spectrum Disorder | Phase 2 | Active not recruiting | Northwestern University | 184 | 2023-07-11 | 2026-10-19 |
| Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children Inhaled Interferon α2b, Standard of Care - COVID-19, Children | Phase 1 / Phase 2 | Terminated | Children's Hospital of Fudan University | 24 | 2022-01-01 | 2023-12-29 |
| Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus GLP-1, SC, Standard Medical Treatment - Type 2 Diabetes | Phase 1 / Phase 2 | Unknown | Diabetes Care Center of Nanjing Military Command | 100 | 2013-10-01 | 2014-02-20 |
| Distress Tolerance Treatment for Substance Users SIDI, SC - Substance Dependence | Phase 2 | Unknown | University of South Florida | 325 | 2013-05-13 | 2018-10-11 |
Autism Spectrum Disorder (1) · Autistic Disorder (1) · COVID-19 (1) · Diabetes Mellitus, Type 2 (1) · Substance-Related Disorders (1)
Children's Hospital of Fudan University (1) · Diabetes Care Center of Nanjing Military Command (1) · Northwestern University (1) · University of South Florida (1)
China (2) · United States (2)